Details for New Drug Application (NDA): 212059
✉ Email this page to a colleague
The generic ingredient in ROSUVASTATIN CALCIUM is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.
Summary for 212059
Tradename: | ROSUVASTATIN CALCIUM |
Applicant: | Zhejiang Yongtai |
Ingredient: | rosuvastatin calcium |
Patents: | 0 |
Pharmacology for NDA: 212059
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for 212059
Suppliers and Packaging for NDA: 212059
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 212059 | ANDA | Solco Healthcare LLC | 43547-591 | 43547-591-09 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-591-09) |
ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 212059 | ANDA | Solco Healthcare LLC | 43547-591 | 43547-591-50 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-591-50) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Nov 4, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Nov 4, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Nov 4, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription